Jazz Pharmaceuticals (JAZZ) Shareholder's Equity Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Jazz Pharmaceuticals | 14.35 Bn | 12.51 Bn | 934.80 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.60% |
| Dec 31, 2025 | 3.37% |
| Sep 30, 2025 | 3.23% |
| Jun 30, 2025 | 3.36% |
| Mar 31, 2025 | 8.25% |
| Dec 31, 2024 | 5.64% |
| Sep 30, 2024 | 6.43% |
| Jun 30, 2024 | 4.75% |
| Mar 31, 2024 | 6.25% |
| Dec 31, 2023 | 6.27% |
| Sep 30, 2023 | 2.88% |
| Jun 30, 2023 | 4.20% |
| Mar 31, 2023 | 3.66% |
| Dec 31, 2022 | 2.61% |
| Sep 30, 2022 | 2.14% |
| Jun 30, 2022 | 7.78% |
| Mar 31, 2022 | 12.71% |
| Dec 31, 2021 | 16.13% |
| Sep 30, 2021 | 16.55% |
| Jun 30, 2021 | 18.06% |
| Mar 31, 2021 | 17.32% |
| Dec 31, 2020 | 16.49% |
| Sep 30, 2020 | 16.65% |
| Jun 30, 2020 | 16.78% |
| Mar 31, 2020 | 16.56% |
| Dec 31, 2019 | 17.80% |
| Sep 30, 2019 | 17.90% |
| Jun 30, 2019 | 18.44% |
| Mar 31, 2019 | 16.61% |
| Dec 31, 2018 | 16.31% |
| Sep 30, 2018 | 19.47% |
| Jun 30, 2018 | 19.54% |
| Mar 31, 2018 | 19.12% |
| Dec 31, 2017 | 19.33% |
| Sep 30, 2017 | 22.75% |
| Jun 30, 2017 | 21.49% |
| Mar 31, 2017 | 20.47% |
| Dec 31, 2016 | 57.65% |
| Sep 30, 2016 | 66.92% |
| Jun 30, 2016 | 77.73% |
| Dec 31, 2015 | 123.57% |